Literature DB >> 923683

Morphine-induced and stimulation-produced analgesias at coincident periaqueductal central gray loci: evaluation of analgesic congruence, tolerance, and cross-tolerance.

V A Lewis, G F Gebhart.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 923683     DOI: 10.1016/0014-4886(77)90119-4

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


× No keyword cloud information.
  8 in total

1.  Opioid peptides, brain and behaviour: a brief review.

Authors:  R J Rodgers
Journal:  Ir J Med Sci       Date:  1978-08       Impact factor: 1.568

Review 2.  Central modulation of pain.

Authors:  Michael H Ossipov; Gregory O Dussor; Frank Porreca
Journal:  J Clin Invest       Date:  2010-11-01       Impact factor: 14.808

Review 3.  Descending pain modulation and chronification of pain.

Authors:  Michael H Ossipov; Kozo Morimura; Frank Porreca
Journal:  Curr Opin Support Palliat Care       Date:  2014-06       Impact factor: 2.302

Review 4.  Inflammatory mediators of opioid tolerance: Implications for dependency and addiction.

Authors:  Lori N Eidson; Anne Z Murphy
Journal:  Peptides       Date:  2019-03-16       Impact factor: 3.750

Review 5.  Supraspinal morphine and descending inhibitions acting on the dorsal horn of the rat.

Authors:  A H Dickenson; D Le Bars
Journal:  J Physiol       Date:  1987-03       Impact factor: 5.182

Review 6.  Endogenous opioids and pain: a review.

Authors:  R G Hill
Journal:  J R Soc Med       Date:  1981-06       Impact factor: 5.344

7.  Lack of evidence for increased descending inhibition on the dorsal horn of the rat following periaqueductal grey morphine microinjections.

Authors:  A H Dickenson; D Le Bars
Journal:  Br J Pharmacol       Date:  1987-10       Impact factor: 8.739

8.  Transcutaneous electrical nerve stimulation at both high and low frequencies activates ventrolateral periaqueductal grey to decrease mechanical hyperalgesia in arthritic rats.

Authors:  J M DeSantana; L F S Da Silva; M A De Resende; K A Sluka
Journal:  Neuroscience       Date:  2009-07-02       Impact factor: 3.590

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.